{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:32:48Z","timestamp":1783571568038,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1016\/s0959-8049(02)00767-0","type":"journal-article","created":{"date-parts":[[2003,3,25]],"date-time":"2003-03-25T22:25:53Z","timestamp":1048631153000},"page":"801-807","source":"Crossref","is-referenced-by-count":37,"title":["Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL)"],"prefix":"10.1016","volume":"39","author":[{"given":"I.","family":"Fichtner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Baumgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-8049(02)00767-0_BIB1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1021\/jm00300a034","article-title":"Studies on epoxide formation from (2S,3S)-Threitol 1,4-Bismethanesulfonate. The preparation and biological activity of (2S,3S)-1,2-Epoxy-3,4-butanediol 4-Methanesulfonate","volume":"13","author":"Feit","year":"1970","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.bjc.6690043","article-title":"DNA alkylation and interstrand cross-linking by treosulfan","volume":"79","author":"Hartley","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB3","first-page":"342","article-title":"Intravenous treosulfan versus intravenous treosulfan plus cisplatinum in advanced ovarian carcinomas","volume":"97","author":"Masding","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/gyno.1998.5103","article-title":"Treosulfan as an effictive second-line therapy in ovarian cancer","volume":"71","author":"Gropp","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB5","first-page":"232","article-title":"High-dose versus low-dose Cisplatin chemotherapy plus Treosulfan in epithelial ovarian carcinoma FIGO II-IV. Results of a prospective randomized trial","volume":"23","author":"Merkle","year":"2000","journal-title":"Onkologie"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00685095","article-title":"Antitumor activity of treosulfan against human breast carcinomas","volume":"31","author":"K\u00f6pf-Maier","year":"1992","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00688319","article-title":"Antitumor activity of treosulfan in human lung carcinomas","volume":"37","author":"K\u00f6pf-Maier","year":"1996","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB8","first-page":"275","article-title":"The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro","volume":"12","author":"K\u00f6pf-Maier","year":"1998","journal-title":"In vivo"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjc.6690237","article-title":"Combination chemotherapy for choroidal melanoma","volume":"79","author":"Neale","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00008390-199904000-00003","article-title":"Treosulfan is an effective alkylating cytostatic for malignant melanoma in vitro and in vivo","volume":"9","author":"Neuber","year":"1999","journal-title":"Mel. Res."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB11","unstructured":"Griskevicius L, Gaughan U, Nilsson C, et al. The myeloablative and immunosuppressive properties of treosulfan in mice, Proceedings 28th Annual Meeting of the European Group for Blood and Marrow Transplantation, March 24\u201327, 2002, Montreux, Switzerland (abstr. 603)."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB12","unstructured":"Melchers I, Rzepka R, Meinel T. Immunosuppressive activity of low dose Treosulfan. Proceedings Joint Annual Meeting of Immunology, November 29\u2013December 2, 2000, Duesseldorf (abstr. 1212)."},{"issue":"Suppl. 1","key":"10.1016\/S0959-8049(02)00767-0_BIB13","first-page":"141","article-title":"Treosulfan as an alternative conditioning agent in bone marrow transplantation","volume":"25","author":"Ploemacher","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB14","unstructured":"Casper J, Knauf W, Steiner D, et al. Toxicity-reduced conditioning with Treosulfan and Fludarabine. Proceedings 43rd Annual Meeting of the American Society of Hematology, December 7\u201311, 2001, Orlando, Fl, (abstr. 786)."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB15","first-page":"39","article-title":"Dihydroxybusulfan (NSC-39069) in chronic myelocytic leukaemia and miscelaneous malignant neoplasms","volume":"42","author":"Loeb","year":"1964","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjc.6600242","article-title":"Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents","volume":"86","author":"Topaly","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB17","unstructured":"Meinhardt GH, Eppinger E, Jahrsdoerfer B. Treosulfan is an effective inducer of cell death in myeloma cells. Proceedings 43rd Annual Meeting of the American Society of Hematology, December 7\u201311, 2001, Orlando, Fl (abstr. 2692)."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/08880010050211349","article-title":"Childhood ALL blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD\/SCID mice","volume":"17","author":"Borgmann","year":"2000","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB19","first-page":"153","article-title":"A phase I dose escalation trial of intravenous treosulfan in refractory cancer","volume":"19","author":"Harstrick","year":"1996","journal-title":"Onkologie"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB20","first-page":"4209","article-title":"Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies","volume":"6","author":"Scheulen","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"Suppl. 1","key":"10.1016\/S0959-8049(02)00767-0_BIB21","first-page":"33","article-title":"Tandem high-dose chemotherapy for advanced ovarian carcinoma","volume":"26","author":"Wagner","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0959-8049(02)00767-0_BIB22","unstructured":"Baynes, R.D., Parchment, R., Dansey, R.D., et al., High-dose melphalan, DTIC and treosulfan (MDT) and PBPCT in previously treated metastatic breast and ovarian cancer, Proceedings. 36th Annual Meeting of the American Society of Clinical Oncology, May 20\u201323, 2000, New Orleans. Louisiana (abstr. 585)."},{"key":"10.1016\/S0959-8049(02)00767-0_BIB23","first-page":"5470","article-title":"Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients","volume":"60","author":"Westerhof","year":"2000","journal-title":"Cancer Res."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804902007670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804902007670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T06:57:54Z","timestamp":1553929074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804902007670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0959804902007670"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(02)00767-0","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}